Adding "hemodynamic and fluid leads" to the ECG. Part I: The electrical estimation of BNP, chronic heart failure (CHF) and extracellular fluid (ECF) accumulation

Medical Engineering and Physics

Volumn 36, Issue 7, 2014, Pages 896-904

  Skrabal, Falko ^a   Pichler, Georg P ^a   Gratze, Gerfried ^b   Holler, Albert ^b  

^a Institute for Cardiovascular and Metabolic Medicine   (Austria)

^b KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

Atrial natriuretic peptide; Bioimpedance spectroscopy; Congestive heart failure; Contractility; Electrocardiography

Indexed keywords

CARDIOLOGY; CORRELATION METHODS; ECHOCARDIOGRAPHY; ELECTRODES; PLASMAS; SPECTROSCOPY;

ATRIAL NATRIURETIC PEPTIDES; BINOMIAL LOGISTIC REGRESSIONS; BIO-IMPEDANCE SPECTROSCOPIES; CHRONIC HEART FAILURES; CONGESTIVE HEART FAILURES; CONTRACTILITY; IMPEDANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY;

ELECTROCARDIOGRAPHY;

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; ELECTROCARDIOGRAPH ELECTRODE; ELECTROCARDIOGRAPHY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HUMAN; HYPERVOLEMIA; INTRACELLULAR FLUID; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; ALGORITHM; BLOOD; CHRONIC DISEASE; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; ELECTROENCEPHALOGRAPHY; IMPEDANCE CARDIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; WATER-ELECTROLYTE IMBALANCE;

ADULT; AGED; ALGORITHMS; CARDIOGRAPHY, IMPEDANCE; CHRONIC DISEASE; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROENCEPHALOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WATER-ELECTROLYTE IMBALANCE;

EID: 84901686679     PISSN: 13504533     EISSN: 18734030     Source Type: Journal    
DOI: 10.1016/j.medengphy.2014.03.015     Document Type: Article

References (52)

1. Luscher T.F. Diagnosis of CHF - often a trap in itself. J Renin Angiotensin Aldosterone Syst 2000, 1(1):7-11.
2. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
3. O'Shea P., Daly R., Kasim S., Tormey W.P. B-type natriuretic peptide in the cardiology department. Irish Med J 2012, 105:341-343.
4. Panagopoulou V., Deftereos S., Kossyvakis C., Raisakis K., Giannopoulos G., Bouras G., et al. NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem 2013, 13:82-94.
5. Ezekowitz J.A., Bakal J.A., Huber K., Theroux P., James S.K., Betriu A., et al. NT-proBNP is an important independent predictor of clinical events after primary PCI for STEMI. Circulation 2008, 118. S582-S3.
6. Germing A., Gotzmann M., Schikowski T., Vierkotter A., Ranft U., Kramer U., et al. High frequency of diastolic dysfunction in a population-based cohort of elderly women - but poor association with the symptom dyspnea. BMC Geriatr 2011, 11:71.
7. Lam L.L., Cameron P.A., Schneider H.G., Abramson M.J., Mueller C., Krum H. Meta-analysis. Effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting. Ann Intern Med 2010, 153. 728-W243.
8. Bruneau B.G., Piazza L.A., de Bold A.J. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol-Heart Circul Physiol 1997, 273:H2678-H2686.
9. Capomolla S., Febo O., Riccardi G., Parziale P., Pinna G., Opasich C., et al. Peak summation left ventricular filling pattern in patients with chronic heart failure: frequency and complementary value of pulmonary venous flow in its hemodynamic interpretation. Echocardiogr J Cardiovasc Ultrasound Allied Tech 1998, 15:721-730.
10. Sabbah H.N., Gheorghiade M., Smith S.T., Frank D.M., Stein P.D. Serial evaluation of left-ventricular function in congestive heart-failure by measurement of peak aortic blood acceleration. Am J Cardiol 1988, 61:367-370.
11. Sabbah H.N., Khaja F., Brymer J.F., McFarland T.M., Albert D.E., Snyder J.E., et al. Noninvasive evaluation of left-ventricular performance based on peak aortic blood acceleration measured with a continuous-wave doppler velocity meter. Circulation 1986, 74:323-329.
12. Noble T.J., Morice A.H., Channer K.S., Milnes P., Harris N.D., Brown B.H. Monitoring patients with left ventricular failure by electrical impedance tomography. Eur J Heart Fail 1999, 1:379-384.
13. Zlochiver S., Radai M.M., Barak-Shinar D., Ben-Gal T., Yaari V., Strasberg B., et al. Monitoring lung resistivity changes in congestive heart failure patients using the bioimpedance technique. Congest Heart Fail 2005, 11:289-293.
14. Yu C.M., Wang L., Chau E., Chan R.H., Kong S.L., Tang M.O., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005, 112:841-848.
15. Kamath S.A., Drazner M.H., Tasissa G., Rogers J.G., Stevenson L.W., Yancy C.W. Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial. Am Heart J 2009, 158:217-223.
16. Milzman D., Napoli A., Hogan C., Zlidenny A., Janchar T. Thoracic impedance vs chest radiograph to diagnose acute pulmonary edema in the ED. Am J Emerg Med 2009, 27:770-775.
17. Joseph G., MacRae J.M., Heidenheim A.P., Lindsay R.M. Extravascular lung water and peripheral volume status in hemodialysis patients with and without a history of heart failure. ASAIO J 2006, 52:423-429.
18. Jaffrin M., Fenech M., Moreno M., Kieffer R. Total body water measurement by a modification of the bioimpedance spectroscopy method. Med Bio Eng Comput 2006, 44:873-882.
19. Ward L.C., Czerniec S., Kilbreath S.L. Quantitative bioimpedance spectroscopy for the assessment of lymphoedema. Breast Cancer Res Treatment 2009, 117:541-547.
20. Warren A.G., Janz B.A., Slavin S.A., Borud L.J. The use of bioimpedance analysis to evaluate lymphedema. Ann Plast Surg 2007, 58:541-543.
21. Zhu F., Kotanko P., Handelman G.J., Raimann J.G., Liu L., Carter M., et al. Estimation of normal hydration in dialysis patients using whole body and calf bioimpedance analysis. Physiol Meas 2011, 32:887-902.
22. Bracco D., Berger M.M., Revelly J.P., Schutz Y., Frascarolo P., Chiolero R. Segmental bioelectrical impedance analysis to assess perioperative fluid changes. Crit Care Med 2000, 28:2390-2396.
23. Vorwerk C., Jeyanithi H., Coats T.J. Thoracic electrical bioimpedance: a tool to determine cardiac versus non-cardiac causes of acute dyspnoea in the emergency department. Emerg Med J 2010, 27:359-363.
24. Parrinello G., Paterna S., Di Pasquale P., Torres D., Fatta A., Mezzero M., et al. The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail 2008, 14:676-686.
25. Pimenta J., Paulo C., Mascarenhas J., Gomes A., Azevedo A., Rocha-Goncalves F., et al. BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status. Int J Cardiol 2010, 145:209-214.
26. Malfatto G., Branzi G., Giglio A., Villani A., Facchini C., Ciambellotti F., et al. Transthoracic bioimpedance and brain natriuretic peptide levels accurately indicate additional diastolic dysfunction in patients with chronic advanced systolic heart failure. Eur J Heart Fail 2010, 12:928-935.
27. Jaffrin M.Y., Morel H. Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys 2008, 30:1257-1269.
28. Jaffrin M.Y., Morel H. Measurements of body composition in limbs and trunk using a eight contact electrodes impedancemeter. Med Eng Phys 2009, 31:1079-1086.
29. Madias J.E. Comparison of lead aVR net QRS area and peak-to-peak amplitude as indices of all limb electrocardiogram leads: Implications for the diagnosis, management, and follow-up in patients with heart failure. Med Eng Phys 2012, 34:1037-1040.
30. Hatle L. How to diagnose diastolic heart failure - a consensus statement. Eur Heart J 2007, 28:2421-2423.
31. Eknoyan G., Levin N.W. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification - foreword. Am J Kidney Dis 2002, 39:S14-S266.
32. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 1989, 2:358-367.
33. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gomez J.M., et al. Bioelectrical impedance analysis principles and methods. Clin Nutr 2004, 23:1226-1243.
34. Gratze G., Fortin J., Holler A., Grasenick K., Pfurtscheller G., Wach P., et al. A software package for non-invasive, real-time beat-to-beat monitoring of stroke volume, blood pressure, total peripheral resistance and for assessment of autonomic function. Comput Biol Med 1998, 28:121-142.
35. Zhu F., Kuhlmann M.K., Kaysen G.A., Sarkar S., Kaitwatcharachai C., Khilnani R., et al. Segment-specific resistivity improves body fluid volume estimates from bioimpedance spectroscopy in hemodialysis patients. J Appl Physiol 2006, 100:717-724.
36. Nakatsu T., Shinohata R., Mashima K., Yuki Y., Nishitani A., Toyonaga S., et al. Use of plasma B-type natriuretic peptide level to identify asymptomatic hypertensive patients with abnormal diurnal blood pressure variation profiles: nondippers, extreme dippers, and risers. Hypertens Res 2007, 30:651-658.
37. Picard R.R., Cook R.D. Cross-validation of regression-models. J Am Stat Assoc 1984, 79:575-583.
38. Bland J.M., Altman D.G. Statistical-methods for assessing agreement between 2 methods of clinical measurement. Lancet 1986, 1:307-310.
39. Turner A.A., Lozano-Nieto A., Bouffard M. Generalizability of extracellular-to-intracellular fluid ratio using bio-impedance spectroscopy. Physiol Meas 2006, 27:385-397.
40. Patterson R.P. Fundamentals of impedance cardiography. IEEE Eng Med Biol Mag 1989, 8:35-38.
41. Matthie J.R. Bioimpedance measurements of human body composition: critical analysis and outlook. Expert Rev Med Dev 2008, 5:239-261.
42. Hayes S., Cornish B., Newman B. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treatment 2005, 89:221-226.
43. Braunwald E. Heart failure. Harrison's Principles of Internal Medicine 1977, 1178-1180. McGraw Hill, New York. 8th ed. G. Thorne, R. Adams, E. Braunwald, K.J. Isselbacher, R.G. Petersdorf (Eds.).
44. Agostoni P., Cattadori G., Apostolo A., Contini M., Palermo P., Marenzi G., et al. Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. J Am Coll Cardiol 2005, 46:1779-1781.
45. Anker S.D., Volterrani M., Egerer K.R., Felton C.V., Kox W.J., Poole-Wilson P.A., et al. Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure. QJM-Monthly J Assoc Phys 1998, 91:199-203.
46. Lee S.W., Song J.H., Kim G.A., Lim H.J., Kim M.J. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 2003, 41:1257-1266.
47. Jacobs L.H., van de Kerkhof J.J., Mingels A.M., Passos V.L., Kleijnen V.W., Mazairac A.H., et al. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Nephrol Dial Transpl 2010, 25:243-248.
48. Lee J.A., Kim D.H., Yoo S.J., Oh D.J., Yu S.H., Kang E.T. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006, 26:360-365.
49. Piccoli A., Pittoni G., Facco E., Favaro E., Pillon L. Relationship between central venous pressure and bioimpedance vector analysis in critically ill patients. Crit Care Med 2000, 28:132-137.
50. Di Somma S., De Berardinis B., Bongiovanni C., Marino R., Ferri E., Alfei B. Use of BNP and bioimpedance to drive therapy in heart failure patients. Congest Heart Fail 2010, 16(Suppl. 1):S56-S61.
51. Piccoli A., Pillon L., Dumler F. Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. Nutrition 2002, 18:153-167.
52. Rose B.D. Edematous states. Clinical physiology of acid-base and electrolyte disorders 2001, 478-523. McGraw-Hill, New York. 5th ed.